| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Disease Serology Lab was featured in a discussion on NBC News about COVID-19 antibody tests.
In May and June 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. Guenzel, a fellow in Laboratory Genetics and Genomics at Mayo Clinic, is the recipient of this award for his publication “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.”
Dr. Mills’ experience working with live cell bio-assays propelled him to centerstage in Mayo Clinic’s pursuit of a test to neutralize COVID-19 antibodies and aid in the development of therapies derived from COVID-19 patients' donated plasma.
On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
A case study published on Practice Greenhealth detailed how the change in freezers will reduce energy use by more than 60% and save more than $6 million over 10 years.
Dr. Binnicker's experience developing Mayo Clinic's first diagnostic COVID-19 test was recently featured in Mayo Clinic Alumni magazine.
Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.
The assay is now recommended for diagnosing and monitoring patients with monoclonal protein disorders and exclusively available through Mayo Clinic Laboratories– Rochester.